IN the last decade great advances have been made in the treatment of hypertension, so that it is now possible in most cases, by the use of drugs, singly or in combination, to reduce raised blood pressure to normal or near normal levels during the 24-hour day. The benefit to be derived from treatment is often great, especially in cases of malignant hypertension, and this is particularly so when treatment is started before there is extensive vascular damage (Harington, Kincaid-Smith and McMichael, 1959) . In less severe degrees of hypertension, there is symptomatic relief, heart failure is usually relieved, and improvement often occurs in the electrocardiogram (Dustan, Schneckloth, Corcoran and Page, I959) . Unfortunately when there is much impairment of renal function lowering of the blood pressure may result in progressive renal failure and a further rise of blood urea, and these cases are, therefore, not usually suitable for treatment.
Until recently, the most effective hypotensive drugs blocked transmission of impulses at autonomic ganglia and postural blood pressure control due to paresis of the sympathetic nervous system was often obtained only at the cost of serious side effects due to simultaneous blockage of the parasympathetic ganglia. Great interest was shown, therefore, in new compounds which gave good postural control of the blood pressure by blocking only the sympathetic nervous system without parasympathetic inhibition, first bretylium tosylate (Darenthin) (Boura, Green, McCoubrey, Lawrence, Moulton and Rosenheim, I959) and later guanethidine (Ismelin) (Maxwell, Mull and Plummer, 1959 Benzthiadiazine diuretics, and, to a lesser extent, Rauwolfia alkaloids, potentiate the action of guanethidine, so that the addition of a benzthiadiazine diuretic often reduces the amount of guanethidine necessary to obtain a satisfactory fall in blood pressure (Blanshard and Essigman, 196I ).
The commonest side-effect is diarrhcea, but muscle aching and weakness, fluid retention, mental depression and failure of ejaculation may also occur. Side effects occur more frequently when large doses of the drug are given. Nasal stuffiness and parotid pain which were frequent with bretylium tosylate occur very rarely with guanethidine. Moreover, there is no significant development of drug tolerance, which is a great advantage over bretylium.
When pheochromocytoma is present or suspected, guanethidine is contraindicated because it may increase the pressor response to adrenaline and noradrenaline secreted by the tumour, and dangerously high blood pressure may result. Recent coronary or cerebral thrombosis is also a contraindication to immediate treatment, but treatment may be started cautiously six weeks later when especial care must be taken to avoid episodes of hypotension. Where angina of less than one year's duration is present, hypotensive therapy may be combined with anticoagulants.
We report here our experience of the use of guanethidine (Ismelin, Ciba) 
Subjects
Twenty patients (i6 women and four men) have been treated for periods up to 20 months; the mean duration of treatment being I 1.7 months. Their average age was 49 years (range i8 to 65 years). The patients were admitted to hospital from the outpatient department or directly as an emergency. In hospital, in addition to a detailed history and clinical examination, daily blood pressure readings were taken after a period of bed rest to determine the basal blood pressure level. All patients had routine chest X-ray examination, electrocardiography, ophthalmoscopic inspection, urinanalysis including microscopy and culture, estimation of blood urea and intravenous pyelography. A phentolamine test and examination for urinary catecholamines were undertaken to exclude pheochromocytoma in all cases. The presenting symptoms were headache (15), dyspncea (6), blurring of vision (2) and dizziness (2). In addition, three had hypertensive cardiac failure, i6 had evidence of left ventricular hypertrophy and strain on electrocardiography, and in io there was cardiac enlargement clinically. Three had Grade IV and four Grade III retinopathy, five had a raised blood urea (greater than 5o mg. %) and eight had persistent proteinuria presumably due to renal damage.
Before starting treatment a persistent elevation of diastolic pressure was demonstrated (Table i) by daily blood pressure readings under basal conditions. Eighteen were considered to be suffering from essential hypertension and in two the hypertension was thought to be secondary to chronic pyelonephritis. Side Effects Diarrhaea, worse in the morning and associated with urgency, occurred in four patients. In three the dose of guanethidine was less than 6o mg. a day but the diarrhaea did not persist in two when the dose was reduced by IO mg. and cyclopenthiazide added, although one required pempidine as well. One patient having 8o mg. guanethidine and a diuretic developed diarrheea which was controlled by a small dose of propantheline. Three patients complained of muscle aching and easy fatigue but these symptoms were transient and did not persist when the stabilization dose had been reached. Severe postural hypotension was not troublesome, and, although six patients complained of a feeling of light-headedness on rising from bed in the morning, lasting five minutes or less, this tended to wear off as treatment continued. None of the patients complained of depression. No evidence of drug tolerance was found, and once the correct dose had been arrived at it did not have to be changed.
Discussion
We have found guanethidine to be an effective drug for lowering elevated blood pressure when given as a single morning dose. It is well tolerated and although diarrhfiea is a fairly frequent side effect this can usually be readily controlled without an increase in blood pressure readings by reducing the dose of guanethidine by io mg. and adding a benzthiadiazine diuretic. If the dose of guanethidine required for blood pressure control is greater than 6o mg. daily, a benzthiadiazine diuretic should be given in addition as the amount of guanethidine required, and, therefore, the incidence of side effects is thereby reduced, and it seems likely that diarrhea would have been a greater problem had we not adopted this policy. There is complete freedom from side effects due to parasympathetic paresis which often made treatment with ganglionic blockage agents difficult, and in contrast to the earlier sympathetic-blocking agent, bretylium tosylate, drug tolerance has not been a problem. The drug has a slow effect and some weeks are often necessary to obtain satisfactory control of the blood pressure. Guanethidine lowered blood pressure satisfactorily in 2o hypertensive patients and subjective and objective benefit resulted. A combination of guanethidine and a benzthiadiazine diuretic reduces the amount of guanethidine necessary to control the elevated blood pressure, and this combination enables side effects of the drug to be controlled. If more than 6o mg. of guanethidine are necessary for satisfactory control of blood pressure, we recommend that a benzthiadiazine diuretic should always be given simultaneously.
